Single brain metastases from unknown primary malignancies in CT-era
- 1 January 1995
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 23 (1) , 75-80
- https://doi.org/10.1007/bf01058462
Abstract
Cerebral metastases account for about half of all intracranial neoplasms. In 33%–66% they represent the first sign of a systemic tumor. We report our experience in 100 patients with solitary brain metastasis from unknown primary malignancies treated between 1976 and 1988. All patients were treated surgically and 81 also received radiotherapy and chemotherapy. Postoperative mortality was 6%. Mean survival in those patients with unknown primary tumor at intracranial surgery was 15.3 months as compared to 31.6 months in those in whom it remained unidentified during life. The usual cause of death was growth of the systemic cancer.Keywords
This publication has 30 references indexed in Scilit:
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990
- Surgery for Metastases to the BrainNew England Journal of Medicine, 1990
- The Role of Postoperative Radiotherapy after Resection of Single Brain MetastasesNeurosurgery, 1989
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989
- Proliferative potential of brain metastasesCancer, 1988
- Distribution of Brain MetastasesArchives of Neurology, 1988
- Metastatic TumorsPublished by Springer Nature ,1986
- Brain Metastasis: Analysis of Patients Without Known CancerSouthern Medical Journal, 1985
- Surgical treatment of brain metastases from lung cancerJournal of Neurosurgery, 1983
- Results of operative treatment of intracranial metastatic tumorsCancer, 1980